Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Vanda Pharmaceuticals (VNDA) Shares Outstanding (2016 - 2025)

Vanda Pharmaceuticals' Shares Outstanding history spans 17 years, with the latest figure at $59.1 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.36% to $59.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $59.1 million, a 1.36% increase, with the full-year FY2025 number at $59.1 million, up 1.36% from a year prior.
  • Shares Outstanding hit $59.1 million in Q4 2025 for Vanda Pharmaceuticals, roughly flat from $59.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding for VNDA hit a ceiling of $59.1 million in Q4 2025 and a floor of $55.6 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $57.4 million across 5 years, with a median of $57.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: grew 2.64% in 2021 and later rose 1.27% in 2025.
  • Tracing VNDA's Shares Outstanding over 5 years: stood at $55.9 million in 2021, then grew by 1.58% to $56.8 million in 2022, then rose by 1.32% to $57.5 million in 2023, then grew by 1.35% to $58.3 million in 2024, then grew by 1.36% to $59.1 million in 2025.
  • Business Quant data shows Shares Outstanding for VNDA at $59.1 million in Q4 2025, $59.1 million in Q3 2025, and $59.1 million in Q2 2025.